Effectiveness of the short-term use of Cimicifuga racemosa in the endothelial function of postmenopausal women: a double-blind, randomized, controlled trial.
- 2019-11-06
- Climacteric : the journal of the International Menopause Society 23(3)
- E S Fernandes
- M F S Celani
- M Fistarol
- S Geber
- PubMed: 31691621
- DOI: 10.1080/13697137.2019.1682542
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- 62 healthy postmenopausal women
- Methods
- Double-blind, randomized, placebo-controlled study; 28 days of 160 mg Cimicifuga racemosa extract (containing 4 mg triterpene glycosides) or placebo
- Blinding
- Double-blind
- Duration
- 28 days
- Funding
- Unclear
Objective: This study aimed to assess the effects of daily use of Cimicifuga racemosa on endothelial function through flow-mediated dilation of the brachial artery, when used for 28 days by healthy postmenopausal women.Methods: The double-blind, randomized, placebo-controlled study included two groups of postmenopausal women (n = 31 each). The subjects were clinically assessed and flow-mediated dilation of the brachial artery was measured before and after 28 days of treatment. Patients received dry extract corresponding to 160 mg C. racemosa (extract with 4 mg of triterpene glycosides) or placebo.Results: Mean age, time since menopause, and body mass index in the two groups were similar. The measurements of flow-mediated dilation of the brachial artery, pre and post treatment, respectively, showed a significant increase in patients who used C. racemosa (p = 0.006), unlike patients who used placebo, who did not present changes in the outcome of flow-mediated dilation of the brachial artery after 28 days of use (p ≥ 0.05). When comparing the number of women in both groups who showed an increase in flow-mediated dilation, a significant difference was found in the measurements of the treated group after the use of the medication (p = 0.018).Conclusions: Daily use of 160 mg C. racemosa extract by postmenopausal women for 28 days beneficially influences endothelial function by promoting elasticity of the brachial artery.
Research Insights
The measurements of flow-mediated dilation of the brachial artery, pre and post treatment, respectively, showed a significant increase in patients who used C. racemosa (p=0.006)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 160 mg/day